A European and a Canadian multicenter randomized, double-blind trial of the sirolimus-eluting stent (SES) in patients with de novo native coronary artery lesions (NEW-SIRIUS):: 4-year clinical outcomes

被引：0
|
作者：
Schampaert, Erick
Schofer, Joachim
Breithardt, Gunter
Cohen, Eric A.
Schluter, Michael
Wichter, Thomas
机构：
[1] Hop Sacre Coeur Montreal, Ctr Cardiovasc, Montreal, PQ H4J 1C5, Canada
[2] Univ Hamburg, Hamburg, Germany
[3] Univ Hosp Munster, Munster, Germany
[4] Sunnybrook & Womens Coll Hlth Sci Ctr, Toronto, ON, Canada
来源：
AMERICAN JOURNAL OF CARDIOLOGY | 2006年 / 98卷 / 8A期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：156M / 156M
页数：1
相关论文
共 50 条
  • [21] Efficacy and safety at 3 years of the sirolimus-eluting stent for the treatment of patients with long lesions in small vessels from the Canadian multicenter, randomized, double-blind trial C-SIRIUS
    Schampaert, E
    Cohen, EA
    Reeves, F
    Palisaitis, DA
    Traboulsi, M
    Title, L
    O'Neill, BJ
    Raco, D
    Mildenberger, RR
    Plante, S
    Roy, L
    AMERICAN JOURNAL OF CARDIOLOGY, 2005, 96 (7A): : 53H - 54H
  • [22] The SIRIUS-DIRECT trial: A multi-center study of direct stenting using the sirolimus-eluting stent in patients with de novo native coronary artery lesions
    Moses, Jeffrey W.
    Weisz, Giora
    Mishkel, Gregory
    Caputo, Ronald
    O'Shaughnessey, Charles
    Wong, S. Chiu
    Fischell, Tim A.
    Mooney, Michael
    Williams, David O.
    Popma, Jeffrey J.
    Fitzgerald, Peter
    Smith, Sidney
    Kuntz, Richard E.
    Collins, Michael
    Cohen, Sidney A.
    Leon, Martin B.
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2007, 70 (04) : 505 - 512
  • [23] Safety and efficacy of the 2.25mm sirolimus-eluting BX Velocity™ stent in the treatment of patients with de novo native coronary artery lesions:: The SIRIUS 2.25 trial
    Moses, JW
    Cohen, SA
    Mehran, R
    Cambier, P
    Bachinsky, B
    Leya, F
    Kuntz, R
    Popma, J
    Leon, MB
    CIRCULATION, 2005, 112 (17) : U538 - U538
  • [24] Safety and efficacy of the 2.25-mm sirolimus-eluting Bx Velocity stent in the treatment of patients with de novo native coronary artery lesions: the SIRIUS 2.25 trial
    Moses, Jeffrey W.
    Nikolsky, Eugenia
    Mehran, Roxana
    Cambier, Patrick A.
    Bachinsky, William B.
    Leya, Fred
    Kuntz, Richard E.
    Popma, Jeffrey J.
    Schleckser, Patricia
    Wang, Hong
    Cohn, Sidney A.
    Leon, Martin B.
    AMERICAN JOURNAL OF CARDIOLOGY, 2006, 98 (11): : 1455 - 1460
  • [25] Analysis of 1-year clinical outcomes in the SIRIUS trial - A randomized trial of a sirolimus-eluting stent versus a standard stent in patients at high risk for coronary restenosis
    Holmes, DR
    Leon, MB
    Moses, JW
    Popma, JJ
    Cutlip, D
    Fitzgerald, PJ
    Brown, C
    Fischell, T
    Wong, SC
    Midei, M
    Snead, D
    Kuntz, RE
    CIRCULATION, 2004, 109 (05) : 634 - 640
  • [26] One-year follow-up of the SIRIUS study: A randomized study with the sirolimus-eluting Bx VELOCITY in the treatment of patients with de-novo native coronary artery lesions
    Holmes, DR
    Leon, MB
    Moses, JW
    Midwall, J
    Clark, M
    Palacios, I
    Bates, M
    Lopez, J
    Yeung, AC
    Kuntz, RE
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (06) : 32A - 33A
  • [27] A randomized trial of the endeavor drug (ABT-578) eluting stent system versus the cypher sirolimus-eluting coronary Stent system in de novo native coronary artery lesions: ENDEAVOR III
    Kandzari, DE
    O'Shaunessy, C
    Ball, M
    Turco, M
    Kuntz, RE
    Fitzgerald, P
    Popma, JJ
    Leon, MB
    CIRCULATION, 2005, 112 (17) : U611 - U611
  • [28] A Prospective Randomized Multicenter Study to Assess the Safety and Effectiveness of the Orsiro Sirolimus-Eluting Stent in the Treatment of Subjects With Up to 2 De Novo Coronary Artery Lesions-BIOFLOW IV: 4-Year Clinical Results
    Slagboom, Ton
    Toelg, Ralph
    Witzenbichler, Bernhard
    Haude, Michael
    Jose Ruiz-Salmeron, Rafael
    Witkowski, Adam
    Waksman, Ron
    Saito, Shigeru
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 74 (13) : B43 - B43
  • [29] The US multicenter, randomized, double-blind study of the Sirolimus-eluting stent in coronary lesions: Early (30-day) safety results
    Moses, JW
    Leon, MB
    Popma, JJ
    Kuntz, RE
    CIRCULATION, 2001, 104 (17) : 464 - 464
  • [30] Five-year results of the Multicenter Randomized Controlled Open-Label Study of the CYPHER Sirolimus-Eluting Stent in the Treatment of Diabetic Patients with De Novo Native Coronary Artery Lesions (SCORPIUS) study: A German multicenter investigation on the effectiveness of sirolimus-eluting stents in diabetic patients
    Sinning, Jan-Malte
    Baumgart, Dietrich
    Werner, Nikos
    Klauss, Volker
    Baer, Frank M.
    Hartmann, Franz
    Drexler, Helmut
    Motz, Wolfgang
    Klues, Heinrich
    Voelker, Wolfram
    Pfannebecker, Thomas
    Stoll, Hans-Peter
    Nickenig, Georg
    AMERICAN HEART JOURNAL, 2012, 163 (03) : 446 - U397
12345